by Stacey Johnson | Jun 10, 2022
The race to produce lab grown food marches on. So where are we in 2022? Two years ago, blogger Elisa D’Arcangelo outlined some of the practical issues associated with developing lab grown meat – namely cost, increasing production and taste. She also explained the...
by Cal Strode | May 26, 2022
In part 1 of this feature marking the 10-year anniversary of Signals, we got to know the people behind the posts a little better. Now, we’re looking to the future of regenerative medicine and science with the help of our contributors. In this post, bloggers Lyla...
by Cal Strode | May 18, 2022
To mark Signals’ 10-year anniversary, we caught up with some of our active current bloggers — Lyla El-Fayomi, David Kent and Sara Nolte — to get to know them a little better, talk science communication and, in next week’s follow-up post, predict what a science-enabled...
by Cal Strode | May 11, 2022
When Signals first burst onto the scene in 2012, the potential of the regenerative medicine industry still hadn’t set in for many. When the Alliance for Regenerative Medicine (ARM) published its first state of the industry report in 2012, the ARM chairman at the time,...
by Lyla El-Fayomi | May 10, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. April was full of great research and big...
by Stacey Johnson | May 6, 2022
This month is the 10-year anniversary of when Lisa Willemse and I launched Signals. As you would imagine, blogs come and go so 10 years is a significant milestone. It is also my 10-year anniversary at CCRM and when I was introduced to the regenerative medicine field....
by Sara M. Nolte | Apr 28, 2022
If I were to ask you to think of a genetic disease that should be a priority for gene therapy research, you might say breast cancer, Huntington’s, or cystic fibrosis. And these are all great candidates. But I’d say you’re missing a big one. Sickle cell disease (SCD)...
by Krystal Jacques | Apr 21, 2022
It’s been all over the news for the last two weeks. Diljeet Gill and colleagues at the Babraham Institute in England are investigating a novel way to reverse aging of skin, opening the door to creating a new possible cell therapy. Their work largely originates from...
by Stacey Johnson | Apr 15, 2022
Every day, it seems there is a new podcast vying for our attention. In specific terms, in 2021 there were 850,000 active podcasts with over 48 million total episodes. (Curious for more podcast stats? Check out this blog by Neal Schaffer.) Podcasts are positively...
Comments